Common Contracts
3 similar null contracts by BioAmber Inc., Parallax Health Sciences, Inc., Sontra Medical Corp
THIS WARRANT AND THE SHARES OF COMMON STOCK ISSUED UPON ITS EXERCISE ARE SUBJECT TO THE RESTRICTIONS ON TRANSFER SET FORTH IN SECTION 5 OF THIS WARRANTParallax Health Sciences, Inc. • June 22nd, 2018 • Retail-drug stores and proprietary stores • California
PARALLAX HEALTH SCIENCES, INC., a Nevada corporation (the “Company”), for value received, hereby certifies that __________________________________, or its registered assigns (the “Registered Holder”), is entitled, subject to the terms and conditions set forth below, to purchase from the Company, at any time or from time to time on or after the date of issuance and on or before 6:00 p.m. PST on June 18, 2021, 6,000,000 shares (subject to adjustment as set forth herein) of Common Stock, $0.001 par value per share, of the Company (“Common Stock”), at a purchase price of US$.25 per share (subject to adjustment as set forth herein). The shares purchasable upon exercise of this Warrant, and the purchase price per share, each as adjusted from time to time pursuant to the provisions of this Warrant, are hereinafter referred to as the “Warrant Shares” and the “Purchase Price,” respectively.
THIS WARRANT AND THE SHARES OF COMMON STOCK ISSUED UPON ITS EXERCISE ARE SUBJECT TO THE RESTRICTIONS ON TRANSFER SET FORTH IN SECTION 5 OF THIS WARRANTBioAmber Inc. • December 22nd, 2011 • Industrial organic chemicals • Delaware
DNP GREEN TECHNOLOGY, INC., a Delaware corporation (the “Company”), for value received, hereby certifies that FCPR SOFINNOVA CAPITAL VI, or its registered assigns (the “Registered Holder”), is entitled, subject to the terms and conditions set forth below, to purchase from the Company, at any time or from time to time on or after the date of issuance and on or before 5:00 p.m. (New York City time) on June 22, 2019, 5,970 shares (subject to adjustment as set forth herein) of Common Stock, $0.01 par value per share, of the Company (“Common Stock”), at a purchase price of US$201.00 per share (subject to adjustment as set forth herein). The shares purchasable upon exercise of this Warrant, and the purchase price per share, each as adjusted from time to time pursuant to the provisions of this Warrant, are hereinafter referred to as the “Warrant Shares” and the “Purchase Price,” respectively.
Form of Warrant] THIS WARRANT AND THE SHARES OF COMMON STOCK ISSUED UPON ITS EXERCISE ARE SUBJECT TO THE RESTRICTIONS ON TRANSFER SET FORTH IN SECTION 4 OF THIS WARRANTSontra Medical Corp • June 18th, 2007 • Electromedical & electrotherapeutic apparatus • Massachusetts
Sontra Medical Corporation, a Minnesota corporation (the “Company”), for value received, hereby certifies that , or its registered assigns (the “Registered Holder”), is entitled, subject to the terms and conditions set forth below, to purchase from the Company, at any time or from time to time on or after the date of issuance and on or before 5:00 p.m. (New York time) on the fifth anniversary hereof, shares of Common Stock, U.S.$0.01 par value per share, of the Company, at a purchase price of U.S.$1.40 per share. The shares purchasable upon exercise of this Warrant, and the purchase price per share, each as adjusted from time to time pursuant to the provisions of this Warrant, are hereinafter referred to as the “Warrant Shares” and the “Purchase Price,” respectively.
